Transcription of 07.234 Hepatitis B Vaccine Biological Page
{{id}} {{{paragraph}}}
Example: dental hygienist
07.234 Hepatitis B Vaccine Biological Page
Alberta Health Services Standard # January 1, 2020 Immunization Program Standards Manual Page 1 of 16 Population, Public and Indigenous Health Hepatitis B Vaccine Biological Page Section 7: Biological Product Information Standard #: Created by: Province-wide Immunization Program Standards and Quality Approved by: Province-wide Immunization Program, Standards and Quality Approval Date: March 1, 2013 Revised: January 1, 2020 Recombivax HB Engerix -B Manufacturer Merck Canada Inc. GlaxoSmithKline Inc. Biological Classification Inactivated: Recombinant Indications for Provincially Funded Vaccine Pre-exposure: Refer to Serology Recommendations and Follow-up section at end of document for pre-immunization serology recommendations.
immunosuppressive medications including but not limited to Imuran® or TNF antagonists like Remicade® or Humira®. Individuals with chronic liver disease from any cause, including hepatitis C infection. Notes: Individuals with chronic liver disease withlab confirmation of positive anti …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: